CIK 0001137883
- Non-accelerated filer
- Smaller reporting company
BRAINSTORM CELL THERAPEUTICS INC.
Sign in to watch- Ticker
- BCLI
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 207273918
- Phone
- +1 201-488-0460
- Business address
- 1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, 10019
- Former names
- BRAINSTORM CELL THERAPEUTICS INC, GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 77 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-03-15 | Almenoff June Sherie Director | Grant or award | +5,700 | $3.50 | $20K | 5,700 |
| 2018-03-06 | Kern Ralph Dr. COO and Chief Medical Officer | Grant or award | +35,885 | 76,770 | ||
| 2018-02-26 | Araya Arturo Director | Grant or award | +4,152 | 7,164 | ||
| 2018-02-01 | Polverino Anthony J. Director | Grant or award | +3,623 | 3,623 | ||
| 2017-11-20 | Rubin Eyal CFO and Treasurer | Grant or award | +25,000 | 25,000 | ||
| 2017-11-20 | Rubin Eyal CFO and Treasurer | Grant or award · Stock Option (right to buy) | +93,686 | 93,686 | ||
| 2017-11-10 | SHORR ROBERT G L Director | Grant or award | +8,666 | 45,731 | ||
| 2017-11-10 | ARBEL IRIT Director | Grant or award · Stock Option (right to buy) | +25,333 | 25,333 | ||
| 2017-11-10 | Yablonka Uri EVP and Chief Business Officer | Grant or award · Stock Option (right to buy) | +13,333 | 13,333 | ||
| 2017-11-10 | TAUB MALCOLM S Director | Grant or award | +12,000 | 29,332 | ||
| 2017-11-10 | Schor Chen Director | Grant or award | +2,000 | 123,558 | ||
| 2017-08-31 | ARBEL IRIT Director | Purchase | +2,500 | $4.26 | $11K | 155,833 |
| 2017-08-23 | Yablonka Uri EVP & Chief Business Officer | Purchase | +2,000 | $3.98 | $8K | 7,543 |
| 2017-07-26 | Lebovits Chaim See Remarks | Grant or award | +31,185 | 2,103,785 | ||
| 2017-07-26 | Lebovits Chaim See Remarks | Grant or award · Stock Option (right to buy) | +41,580 | 41,580 | ||
| 2017-07-13 | ARBEL IRIT Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2017-07-13 | Yablonka Uri EVP & Chief Business Officer | Grant or award | +5,543 | 5,543 | ||
| 2017-03-06 | Kern Ralph Dr. COO and Chief Medical Officer | Grant or award | +35,885 | 35,885 | ||
| 2017-03-06 | Kern Ralph Dr. COO and Chief Medical Officer | Grant or award · Stock Option (right to buy) | +47,847 | 47,847 | ||
| 2017-02-26 | Araya Arturo Director | Grant or award | +3,012 | 3,012 |
Page 8 of 14 · 274 trades